Literature DB >> 20457941

RNPC1, an RNA-binding protein and a target of the p53 family, regulates p63 expression through mRNA stability.

Jin Zhang1, Seong Jun Cho, Xinbin Chen.   

Abstract

P63, a p53 family tumor suppressor, is involved in many cellular processes, including growth suppression and differentiation. Thus, p63 activity needs to be tightly controlled. Here, we found that RNPC1, a RNA-binding protein and a target of the p53 family, regulates p63 mRNA stability and consequently p63 activity. Specifically, we showed that overexpression of RNPC1 decreases, whereas knockdown of RNPC1 increases, the half-life of p63 transcript, which leads to altered p63 expression. Consistent with this, we showed that RNPC1 binds the AU-/U-rich elements in p63 3' UTR in vitro and in vivo and the RRM domain in RNPC1 is required for binding, and regulating the stability of, p63 transcript. Furthermore, we showed that RNPC1 promotes keratinocyte differentiation by repressing p63 expression. Together, we uncovered a previously undetected mechanism by which p63 expression is regulated via mRNA stability and a novel regulatory feedback loop between RNPC1 and p63.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20457941      PMCID: PMC2906842          DOI: 10.1073/pnas.0912594107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27.

Authors:  P Ianakiev; M W Kilpatrick; I Toudjarska; D Basel; P Beighton; P Tsipouras
Journal:  Am J Hum Genet       Date:  2000-06-05       Impact factor: 11.025

2.  Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63.

Authors:  J A McGrath; P H Duijf; V Doetsch; A D Irvine; R de Waal ; K R Vanmolkot; V Wessagowit; A Kelly; D J Atherton; W A Griffiths; S J Orlow; A van Haeringen; M G Ausems; A Yang; F McKeon; M A Bamshad; H G Brunner; B C Hamel; H van Bokhoven
Journal:  Hum Mol Genet       Date:  2001-02-01       Impact factor: 6.150

3.  Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome.

Authors:  J Celli; P Duijf; B C Hamel; M Bamshad; B Kramer; A P Smits; R Newbury-Ecob; R C Hennekam; G Van Buggenhout; A van Haeringen; C G Woods; A J van Essen; R de Waal; G Vriend; D A Haber; A Yang; F McKeon; H G Brunner; H van Bokhoven
Journal:  Cell       Date:  1999-10-15       Impact factor: 41.582

Review 4.  P63 and P73: P53 mimics, menaces and more.

Authors:  A Yang; F McKeon
Journal:  Nat Rev Mol Cell Biol       Date:  2000-12       Impact factor: 94.444

5.  TP63 gene mutation in ADULT syndrome.

Authors:  J Amiel; G Bougeard; C Francannet; V Raclin; A Munnich; S Lyonnet; T Frebourg
Journal:  Eur J Hum Genet       Date:  2001-08       Impact factor: 4.246

Review 6.  On the shoulders of giants: p63, p73 and the rise of p53.

Authors:  Annie Yang; Mourad Kaghad; Daniel Caput; Frank McKeon
Journal:  Trends Genet       Date:  2002-02       Impact factor: 11.639

7.  p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.

Authors:  M Dohn; S Zhang; X Chen
Journal:  Oncogene       Date:  2001-05-31       Impact factor: 9.867

8.  Down-regulation of p63 is required for epidermal UV-B-induced apoptosis.

Authors:  K M Liefer; M I Koster; X J Wang; A Yang; F McKeon; D R Roop
Journal:  Cancer Res       Date:  2000-08-01       Impact factor: 12.701

9.  Retinoic acid inhibits downregulation of DeltaNp63alpha expression during terminal differentiation of human primary keratinocytes.

Authors:  Casimir Bamberger; Dieter Pollet; Hartwig Schmale
Journal:  J Invest Dermatol       Date:  2002-01       Impact factor: 8.551

Review 10.  Posttranscriptional regulation of p53 and its targets by RNA-binding proteins.

Authors:  Jin Zhang; Xinbin Chen
Journal:  Curr Mol Med       Date:  2008-12       Impact factor: 2.222

View more
  47 in total

1.  Serine 195 phosphorylation in the RNA-binding protein Rbm38 increases p63 expression by modulating Rbm38's interaction with the Ago2-miR203 complex.

Authors:  Yanhong Zhang; Xiuli Feng; Wenqiang Sun; Jin Zhang; Xinbin Chen
Journal:  J Biol Chem       Date:  2018-12-19       Impact factor: 5.157

2.  Regulation of CCN1 via the 3'-untranslated region.

Authors:  Yosuke Nakagawa; Masanao Minato; Kumi Sumiyoshi; Aya Maeda; Chikako Hara; Yurika Murase; Takashi Nishida; Satoshi Kubota; Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2013-05-16       Impact factor: 5.782

Review 3.  RBM38 in cancer: role and mechanism.

Authors:  Cheng Zou; Ying Wan; Lingjing He; Jin Hai Zheng; Yang Mei; Junfeng Shi; Min Zhang; Zhiqiang Dong; Dingxiao Zhang
Journal:  Cell Mol Life Sci       Date:  2020-07-08       Impact factor: 9.261

4.  Iron Regulatory Protein 2 Exerts its Oncogenic Activities by Suppressing TAp63 Expression.

Authors:  Yanhong Zhang; Xiuli Feng; Jin Zhang; Xinbin Chen
Journal:  Mol Cancer Res       Date:  2020-04-10       Impact factor: 5.852

5.  Translational repression of p53 by RNPC1, a p53 target overexpressed in lymphomas.

Authors:  Jin Zhang; Seong-Jun Cho; Limin Shu; Wensheng Yan; Teri Guerrero; Michael Kent; Katherine Skorupski; Hongwu Chen; Xinbin Chen
Journal:  Genes Dev       Date:  2011-07-15       Impact factor: 11.361

6.  RNPC1, an RNA-binding protein and a p53 target, regulates macrophage inhibitory cytokine-1 (MIC-1) expression through mRNA stability.

Authors:  Tiffany Yin; Seong-Jun Cho; Xinbin Chen
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

7.  Arsenic suppresses cell survival via Pirh2-mediated proteasomal degradation of ΔNp63 protein.

Authors:  Wensheng Yan; Xiufang Chen; Yanhong Zhang; Jin Zhang; Yong-Sam Jung; Xinbin Chen
Journal:  J Biol Chem       Date:  2012-12-27       Impact factor: 5.157

8.  p53-directed translational control can shape and expand the universe of p53 target genes.

Authors:  S Zaccara; T Tebaldi; C Pederiva; Y Ciribilli; A Bisio; A Inga
Journal:  Cell Death Differ       Date:  2014-06-13       Impact factor: 15.828

9.  p73 expression is regulated by RNPC1, a target of the p53 family, via mRNA stability.

Authors:  Wensheng Yan; Jin Zhang; Yanhong Zhang; Yong-Sam Jung; Xinbin Chen
Journal:  Mol Cell Biol       Date:  2012-04-16       Impact factor: 4.272

10.  DeltaNp63, a target of DEC1 and histone deacetylase 2, modulates the efficacy of histone deacetylase inhibitors in growth suppression and keratinocyte differentiation.

Authors:  Yingjuan Qian; Yong-Sam Jung; Xinbin Chen
Journal:  J Biol Chem       Date:  2011-02-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.